Studies on Prn Variation in the Mouse Model and Comparison with Epidemiological Data
Open Access
- 25 March 2011
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 6 (3) , e18014
- https://doi.org/10.1371/journal.pone.0018014
Abstract
The virulence factor pertactin (Prn) is a component of pertussis vaccines and one of the most polymorphic Bordetella pertussis antigens. After the introduction of vaccination shifts in predominant Prn types were observed and strains with the Prn vaccine type (Prn1) were replaced by strains carrying non-vaccine types (Prn2 and Prn3), suggesting vaccine-driven selection. The aim of this study was to elucidate the shifts observed in Prn variants. We show that, although Prn2 and Prn3 circulated in similar frequencies in the 1970s and 1980s, in the 1990s Prn2 strains expanded and Prn3 strains disappeared, suggesting that in vaccinated populations Prn2 strains are fitter than Prn3 strains. We established a role for Prn in the mouse model by showing that a Prn knock-out (Prn-ko) mutation reduced colonization in trachea and lungs. Restoration of the mutation resulted in a significant increase in colonization compared to the knock-out mutant. The ability of clinical isolates with different Prn variants to colonize the mouse lung was compared. Although these isolates were also polymorphic at other loci, only variation in the promoter for pertussis toxin (ptxP) and Prn were found to contribute significantly to differences in colonization. Analysis of a subset of strains with the same ptxP allele revealed that the ability to colonize mice decreased in the order Prn1>Prn2 and Prn3. Our results are consistent with the predominance of Prn1 strains in unvaccinated populations. Our results show that ability to colonize mice is practically the same for Prn2 and Prn3. Therefore other factors may have contributed to the predominance of Prn2 in vaccinated populations. The mouse model may be useful to assess and predict changes in the B. pertussis population due to vaccination.Keywords
This publication has 61 references indexed in Scilit:
- Comparative genomics of prevaccination and modern Bordetella pertussis strainsBMC Genomics, 2010
- Pertactin Is Required forBordetellaSpecies To Resist Neutrophil-Mediated ClearanceInfection and Immunity, 2010
- Synergic Effect of Genotype Changes in Pertussis Toxin and Pertactin on Adaptation to an Acellular Pertussis Vaccine in the Murine Intranasal Challenge ModelClinical and Vaccine Immunology, 2010
- Bordetella pertussisStrains with Increased Toxin Production Associated with Pertussis ResurgenceEmerging Infectious Diseases, 2009
- Contribution ofBordetella bronchisepticaFilamentous Hemagglutinin and Pertactin to Respiratory Disease in SwineInfection and Immunity, 2009
- Pulsed-Field Gel Electrophoresis, Pertactin, Pertussis Toxin S1 Subunit Polymorphisms, and Surfaceome Analysis of Vaccine and Clinical Bordetella pertussis StrainsClinical and Vaccine Immunology, 2007
- Antigenic Divergence between Bordetella pertussis Clinical Isolates from Moscow, Russia, and Vaccine StrainsClinical and Vaccine Immunology, 2007
- The incidence of Bordetella pertussis infections estimated in the population from a combination of serological surveysJournal of Infection, 2006
- Effect of Acellular Pertussis Vaccine Against Various Strains of Bordetella Pertussis in a Murine Model of Respiratory Infection.Journal of Health Science, 2002
- The construction of a cloning vector designed for gene replacement in Bordetella pertussisGene, 1986